Dynamic Advisor Solutions LLC Sells 4,153 Shares of Intuitive Surgical, Inc. $ISRG

Dynamic Advisor Solutions LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 36.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,342 shares of the medical equipment provider’s stock after selling 4,153 shares during the period. Dynamic Advisor Solutions LLC’s holdings in Intuitive Surgical were worth $4,158,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Kilter Group LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth about $27,000. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at about $27,000. Caitlin John LLC bought a new stake in Intuitive Surgical during the 3rd quarter valued at about $30,000. Finally, Riggs Asset Managment Co. Inc. boosted its position in Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 32,943 shares of company stock worth $17,279,568 in the last three months. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $478.04 on Tuesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The firm has a market cap of $169.77 billion, a P/E ratio of 60.59, a P/E/G ratio of 3.69 and a beta of 1.66. The firm has a 50-day simple moving average of $500.94 and a 200-day simple moving average of $513.62.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. The company’s revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.21 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Barclays set a $712.00 target price on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Raymond James Financial boosted their price target on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Robert W. Baird dropped their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Finally, UBS Group reduced their price objective on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $614.95.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.